Corinaldesi, C.; Ross, R.L.; Abignano, G.; Antinozzi, C.; Marampon, F.; di Luigi, L.; Buch, M.H.; Riccieri, V.; Lenzi, A.; Crescioli, C.;
et al. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. Int. J. Mol. Sci. 2021, 22, 2894.
https://doi.org/10.3390/ijms22062894
AMA Style
Corinaldesi C, Ross RL, Abignano G, Antinozzi C, Marampon F, di Luigi L, Buch MH, Riccieri V, Lenzi A, Crescioli C,
et al. Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences. 2021; 22(6):2894.
https://doi.org/10.3390/ijms22062894
Chicago/Turabian Style
Corinaldesi, Clarissa, Rebecca L. Ross, Giuseppina Abignano, Cristina Antinozzi, Francesco Marampon, Luigi di Luigi, Maya H. Buch, Valeria Riccieri, Andrea Lenzi, Clara Crescioli,
and et al. 2021. "Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition" International Journal of Molecular Sciences 22, no. 6: 2894.
https://doi.org/10.3390/ijms22062894
APA Style
Corinaldesi, C., Ross, R. L., Abignano, G., Antinozzi, C., Marampon, F., di Luigi, L., Buch, M. H., Riccieri, V., Lenzi, A., Crescioli, C., & Del Galdo, F.
(2021). Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences, 22(6), 2894.
https://doi.org/10.3390/ijms22062894